wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39450580-6D83644D-DCF6-4FED-A87E-3A1783DB7F44
Q39450580-6D83644D-DCF6-4FED-A87E-3A1783DB7F44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39450580-6D83644D-DCF6-4FED-A87E-3A1783DB7F44
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.
P2860
Q39450580-6D83644D-DCF6-4FED-A87E-3A1783DB7F44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39450580-6D83644D-DCF6-4FED-A87E-3A1783DB7F44
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
54f1368be2e7a80087e9af590057bf0f9e44e30f
P2860
LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.